J
Joshua Henrina
Researcher at Atma Jaya Catholic University of Indonesia
Publications - 34
Citations - 639
Joshua Henrina is an academic researcher from Atma Jaya Catholic University of Indonesia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 26 publications receiving 215 citations.
Papers
More filters
Journal ArticleDOI
Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis.
RA Tuty Kuswardhani,Joshua Henrina,Raymond Pranata,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients and is prognostically associated with mortality and associated with a composite of poor outcomes.
Journal ArticleDOI
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis.
Raymond Pranata,Joshua Henrina,Michael Anthonius Lim,Sherly Lawrensia,Emir Yonas,Rachel Vania,Ian Huang,Antonia Anna Lukito,Ketut Suastika,RA Tuty Kuswardhani,Siti Setiati +10 more
TL;DR: In this paper, the authors performed a systematic literature search from several electronic databases up until 8 September 2020 and reported that increase in CFS was associated with increase in mortality in a linear fashion, and the potential for a nonlinear relationship based on ORs of each quantitative clinical frailty scale was examined using restricted cubic splines with a three-knots model.
Journal ArticleDOI
The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.
Antonia Anna Lukito,Raymond Pranata,Joshua Henrina,Michael Anthonius Lim,Sherly Lawrensia,Ketut Suastika +5 more
TL;DR: Preliminary findings showed that mortality was lowered in those who consume metformin vs who did not, and given its low cost and widespread availability, met formin is an attractive and potential regimen for mitigating excessive risk in diabetic populations.
Journal ArticleDOI
Diabetes and COVID-19: The past, the present, and the future.
TL;DR: In this paper, the authors proposed that patients with type 1 or type 2 diabetes should be prioritized for vaccination, since they are a high-risk population, and the prevalence of non-communicable diseases is expected to rise due to lifestyle changes and medical issues encountered during the pandemic.
Journal ArticleDOI
Coronavirus Disease of 2019: a Mimicker of Dengue Infection?
Joshua Henrina,Iwan Cahyo Santosa Putra,Sherly Lawrensia,Quinta Febryani Handoyono,Alius Cahyadi +4 more
TL;DR: The importance of knowing similar clinical presentations of both coronavirus diseases and why excluding COVID-19 in the differentials in the setting of a pandemic is imprudent are emphasized.